Pulmonary hypertension in an infant treated with ibuprofen

Indian Journal of Pediatrics

Volumn 80, Issue 8, 2013, Pages 697-699

  Sehgal, Arvind ^a   Kumarshingri, Prasanna S N ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Ibuprofen; Patent ductus arteriosus; Pulmonary hypertension

Indexed keywords

CEFOTAXIME; GENTAMICIN; IBUPROFEN LYSINE; INDOMETACIN; PENICILLIN DERIVATIVE;

ARTICLE; BLOOD CULTURE; CASE REPORT; CPAP DEVICE; ECHOCARDIOGRAPHY; ESCHERICHIA COLI; EXTUBATION; HUMAN; HYPOXEMIA; INFANT; LUNG PRESSURE; MALE; NEWBORN MONITORING; OXYGEN CONSUMPTION; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PULMONARY HYPERTENSION; RESPIRATORY TRACT INTUBATION; SEPSIS;

CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; HUMANS; HYPERTENSION, PULMONARY; IBUPROFEN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; LYSINE;

EID: 84887608128     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-012-0829-2     Document Type: Article

References (10)

1. Gournay V, Savagner C, Thiriez G, Kuster A, Roze JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet. 2002;359:1486-8. (Pubitemid 34457769)
2. Adamska E, Helwich E, Rutkowska M, Zacharska E, Piotrowska A. Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants. Med Weiku Rozwoj. 2005;9:335-54.
3. Bellini C, Campone F, Serra G. Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus. CMAJ. 2006;174:1843-4. (Pubitemid 43974089)
4. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database System Reviews 2011, Issue 7. Art. No.: CD004213. doi: 101002/14651858.CD004213.pub3
5. De Carlos MP, Bersani I, De Rosa G, Cota F, Romagnoli C. Ibuprofen lysinate and sodium ibuprofen for prophylaxis of patent ductus arteriosus in preterm neonates. Indian Pediatr. 2012;49:47-9.
6. Amendolia B, Lynn M, Bhat V, Ritz SB, Aghai ZH. Severe pulmonary hypertension with therapeutic 1-lysine ibuprofen in 2 preterm neonates. Pediatrics. 2012;129:e1360.
7. Erdeve O, Yurttutan S, Altug N, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2011; Dec 5. doi: 10.1136/archdischild-2011-300532
8. Alano MA, Ngougmna E, Ostrea Jr EM, Konduri GG. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics. 2001;107:519-23. (Pubitemid 32183186)
9. Tegeder I, Pfeilschifter J, Geisslinger G. Cycloxygenase independent actions of cyclooxygenase inhibitors. FASEB J. 2001;15:2057-72. (Pubitemid 32927924)
10. Kuniyoshi KM, Brock RS, Gebrekristos BH, et al. Effects of combined hyperoxia and cyclooxygenase inhibition in neonatal rat lungs. Am J Transl Res. 2010;2:332-44.